MAYBANK Kim Eng (MKE) has maintained its "buy" calls on Singapore healthcare plays such as Raffles Medical and Q&M Dental Group as Singapore and Malaysia look to reopen their borders.

DBS Group Research analyst Rachel Tan has kept “buy” on Raffles Medical Group with a raised target price of $1.81 from $1.48. The higher sum-of-the-parts target price took into consideration the historical mean price-to-earnings (P/E) of 34.5 times to FY2022 earnings, plus 20 cents per share for...

The healthcare sector is receiving “another shot in the arm” with gradual reopening in Singapore and Malaysia, say Maybank Kim Eng Research analysts Lai Gene Lih and Eric Ong. In an Oct 13 note, Lai and Ong are upgrade the healthcare sector to “positive”. Reopening is good for healthcare pla...

MAYBANK Kim Eng (MKE) has maintained its "buy" calls on Singapore healthcare plays such as Raffles Medical and Q&M Dental Group as Singapore and Malaysia look to reopen their borders.

MAYBANK Kim Eng (MKE) has maintained its "buy" calls on Singapore healthcare plays such as Raffles Medical and Q&M Dental Group as Singapore and Malaysia look to reopen their borders.

News of the further opening of Singapore’s borders has pushed RHB Group Research to maintain its “buy” call on Raffles Medical, but at a revised target price of $1.65. This is up 20 cents from its previous $1.45 call and is believed to give the counter a 12% upside from its $1.48 price on Oct ...

RAFFLES Medical, the sole provider of Covid-19 polymerase chain reaction (PCR) tests for post-arrival air travellers into Singapore, should benefit from the further reopening of the Republic's borders, RHB said on Monday (Oct 11).

RHB Group Research is maintaining its ‘buy’ call and target price of $1.45 on Raffles Medical Group. This is expected to give the counter a 4% upside from its $1.39 price, analyst Shekhar Jaiswal writes in a Sep 21 note. His move comes despite the tapering of the vaccination programme in Singapo...

Allen Lew, a recently appointed director of Raffles Medical Group, acquired 100,000 shares at $1.35 each on July 27. A day earlier, he had bought another 100,000 shares at $1.30 each. His 200,000 shares is equivalent to 0.011% of the company. Lew, a longtime stalwart at Singapore Telecommunications,...

ANALYSTS are raising their target prices for Raffles Medical Group, after the healthcare services provider beat consensus estimates to post a stellar set of H1 results on the back of a protracted recovery from the Covid-19 pandemic.